• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these drugs could affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of using them against the risks to the fetus. Physicians do not have the information needed to give clear guidelines however they can provide information about risks and benefits that assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers conducted a massive population-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure accurate classification of the cases and to reduce the chance of bias.

The study of the researchers was not without its limitations. Researchers were unable, in the first place to differentiate the effects of the medication from the disorder. This makes it difficult to know whether the small differences observed in the groups that were exposed are due to the use of medication or the confounding effect of comorbidities. The researchers did not study long-term outcomes for the offspring.

The study found that babies whose mothers took ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system-related disorders, and the increased risk for admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean birth or having a baby with a low Apgar score (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit to both the mother and child from continued treatment for the woman's condition. Physicians should discuss this with their patients and, if possible, help them develop strategies for improving their coping skills which can reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or discontinue treatment during pregnancy is one that doctors are having to face. Often, these decisions are made without solid and reliable evidence regardless, so doctors have to weigh their experience about their experiences, the experiences of other doctors, and what research says on the topic and their best judgment for each individual patient.

The issue of risk to the infant can be difficult to determine. The research on this issue is based on observation rather than controlled studies, and a lot of the results are contradictory. In addition, most studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no such relationship and the majority of studies have a neutral or slightly negative effect. As a result, a careful risk/benefit analysis must be done in each case.

For many women with ADHD, the decision to discontinue medication is difficult, if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. The loss of medication can also impact the ability to drive safely and to perform work-related tasks which are crucial aspects of normal life for those with ADHD.

She suggests that women who are not sure whether to take the medication or discontinue it due to pregnancy, educate their family members, colleagues, and their friends about the condition, its effects on daily functioning, and the benefits of keeping the current treatment regimen. It can also help a woman feel confident about her decision. It is important to remember that some medications are able to pass through the placenta so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the medication could be transferred to the child.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns over the counter adhd medication the impact that these medications could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. Using two massive data sets researchers were able analyze more than 4.3 million pregnancies to determine whether stimulant medication use increased the risk of birth defects. Researchers found that while the overall risk is low, the first trimester managing adhd without medication adults exposure to medication was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers of the study did not discover any connection between early use of medication and congenital anomalies like facial deformities or club feet. The findings are in line with previous studies showing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of the time of pregnancy. This risk increased during the latter half of pregnancy when many women decided to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely need a caesarean, have a low Apgar after delivery and had a baby that required help breathing at birth. However the researchers of the study were not able to eliminate bias due to selection by limiting the study to women who did not have any other medical issues that could be a contributing factor to these findings.

Researchers hope their research will help doctors when they see pregnant women. The researchers suggest that, while discussing benefits and risks are crucial, the decision regarding whether or not to stop medication should be made based on the severity of each woman's ADHD symptoms and her needs.

The authors also caution that while discontinuing the medications is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health issues in women who are pregnant or post-partum. Research has also shown that women who stop taking their medications will have a difficult transitioning to life without them once the baby is born.

Nursing

It can be a challenge to become a mom. Women with ADHD may face a lot of challenges when they must deal dealing with adhd without medication their symptoms, go to doctor appointments, prepare for the birth of their child and adjust to a new routine. This is why many women decide to continue taking their ADHD medications throughout pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk at low levels. The rate of medication exposure can vary depending upon the dosage, frequency of administration and the time of the day. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk. The impact of this on a newborn infant is not fully understood.

Some physicians may discontinue stimulant medications during a woman's pregnancy due to the lack of research. It is a difficult decision for the woman, who must weigh the benefits of her medication against the risks to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal time.

A growing number of studies have shown that the majority of women are able to safely continue their ADHD medication during pregnancy and while breastfeeding. This has led to many patients opt to do this and after consulting with their doctor, they have discovered that the benefits of keeping their current medication far exceed any risk.

Women who suffer from ADHD who are planning to nurse should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons for continuing treatment. This includes non medication treatment for private adhd medication cost, https://www.pdc.edu/?url=https://postheaven.net/trainshelf4/the-complete-list-of-adhd-no-medication-dos-and-donts,-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be informed about treatment options and strengthen the coping mechanisms. This should be a multidisciplinary process including obstetricians, GPs, and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if needed, adjustments to the medication regime.